FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/104024 [Registered on: 16/02/2026] Trial Registered Prospectively
Last Modified On: 14/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study to compare two Ayurvedic medicines (Panchmooladi syrup and Shati compound syrup) in the management of Vataja Kasa among children aged 3 to 10 years. 
Scientific Title of Study   A randomized comparative clinical study to evaluate the efficacy of Panchmooladi Syrup and Shati Compound in the management of Vataja Kasa among children aged 3 to 10 years. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Harshal Prakash Kamble 
Designation  PG Scholar 
Affiliation  PDEAs College of Ayurved and Research Centre, Nigdi, Pune  
Address  PDEAs College of Ayurved and Research Centre Balrog Department, Nigdi, Pune Maharashtra 411044, India

Pune
MAHARASHTRA
411044
India 
Phone  9130653964  
Fax    
Email  harshalkamble06@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Deepa Khasgiwala 
Designation  Assistant Professor 
Affiliation  PDEAs College of Ayurved and Research Centre, Nigdi, Pune 
Address  PDEAs College of Ayurved and Research Centre Balrog Department, Nigdi, Pune Maharashtra 411044, India

Pune
MAHARASHTRA
411044
India 
Phone  9890077765  
Fax    
Email  drdeepajain@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Deepa Khasgiwala 
Designation  Assistant Professor 
Affiliation  PDEAs College of Ayurved and Research Centre, Nigdi, Pune 
Address  PDEAs College of Ayurved and Research Centre Balrog Department, Nigdi, Pune Maharashtra 411044, India

Pune
MAHARASHTRA
411044
India 
Phone  9890077765  
Fax    
Email  drdeepajain@yahoo.co.in  
 
Source of Monetary or Material Support  
PDEAs College of Ayurved and Research Centre Sector 25, Pradhikaran, Nigdi, Pune, Maharashtra, 411044, India 
 
Primary Sponsor  
Name  PDEAs College of Ayurved and Research Centre Nigdi, Pune 
Address  PDEAs College of Ayurved and Research Centre Sector 25, Pradhikaran, Nigdi, Pune, 411044 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Harshal Kamble  Ayurved Rugnalaya and Sterling Multispeciality Hospital Nigdi Pradhikaran Pune  Ayurved Rugnalaya and Sterling Multispeciality Hospital Nigdi Pradhikaran Pune Pradhikaran Pune sector 27 Balrog Department OPD No. 118 Pune Maharashtra
Pune
MAHARASHTRA 
9130653964

harshalkamble06@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Chairperson Instititional Ethics Commitee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J00-J06||Acute upper respiratory infections. Ayurveda Condition: VATAJAKASAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugOther than Classical(1) Medicine Name: Shati Compound Syrup, Reference: NA, Route: Oral, Dosage Form: Sharkara/ Syrup, Dose: 0.6(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -The dose in children is given according to the body weight; hence, the given dose is 0.6 ml per kg per day
2Intervention ArmDrugClassical(1) Medicine Name: Panchmooladi Syrup, Reference: Yogaratnakar, Route: Oral, Dosage Form: Sharkara/ Syrup, Dose: 0.6(ml), Frequency: tds, Bhaishajya Kal: Pragbhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -The dose in children is given according to the body weight; hence, the given dose is 0.6 ml per kg per day
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  10.00 Year(s)
Gender  Both 
Details  1) Subjects having any two or more classical signs and symptoms of Vataja Kasa, including shushka Kasa described in the context of Vataja Kasa, such as Shushka Kasa, Shirashoola, Swarabheda, Parshwashoola, Uroshoola, Shushka mukha, and gala.
2) Subjects between the age group of 3 to 10 years irrespective of gender, religion, or socioeconomic status will be taken.
3) Subjects having Kasa with symptoms for less than 7 days duration. 
 
ExclusionCriteria 
Details  1) Kasa as Anubandha Lakshan in other systemic diseases.
2) Patients presenting with symptoms of Tamaka Shwasa (bronchial asthma).
3) Kasa associated with Jwara.
4) Known case of pneumonia, emphysema, diphtheria, pertussis, obstructive bronchitis, bronchiectasis, lung abscess, and pulmonary edema resulting from cardiac and renal diseases.
5) Known case of Kochs, HIV, and other debilitating diseases.
6) Known case of congenital anomalies of the respiratory system. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To compare the efficacy of Panchmooladi syrup and Shati compound in the management of Vataj Kasa in children aged 3 to 10 years over 7 days  7 Days, where Follow up will be on the 3rd, 5th, and 7th day. 
 
Secondary Outcome  
Outcome  TimePoints 
To observe the adverse effects if any  7 Days, where Follow up will be on the 3rd, 5th, and 7th day. 
 
Target Sample Size   Total Sample Size="64"
Sample Size from India="64" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Cough is one of the most common symptoms of respiratory tract infection. It is one of the most common reasons that lead to frequent hospital visits. Cough is an important defense mechanism, but persistent cough interferes with sleep and feeding. It fatigues the child.
In Ayurved, cough is correlated with Kasa. Cough may be a symptom according to modern medicine, but from an ayurvedic point of view, Kasa is a disease. In Ayurveda, there are five types of Kasa: Vataj, Pittaj, Kaphaj, and Kshtaj. The Prana Vayu and Udan Vayu are responsible for the normal functioning of Pranvaha strotas. The vitiation of Prana Vayu and Udan Vayu causes the manifestation of the Kasa. Vataj kasa is characterized by Shushka gala and mukh, Shushka Kasa, Shirshoola, Parshwashoola, Swarbhed and Uroshoola.
                                Management of Kasa in children needs more care and observation since the complications can make the condition worse in the advance stage of the disease. Vataj Kasa resembles a dry cough. The persistent nature of cough and associated symptoms hampers the daily routine activities of life. In modern medicine antitussive treatment is commonly referred antihistamines; decongestants are also used to treat symptoms.
                       Ayurved offers safe and effective remedies with minimal side effects. Many herbal compositions for Kasa are documented in Ayurveda. While Panchmooladi Kwatha, addressed in Yogratnakar, has been specifically mentioned in the management of Vataj Kasa. Also, according to Charak Samhita, mild, sweet, and palatable medicines should be used in children. So opted for Panchmooladi Syrup formulation.
 
Close